Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Response Genetics starts researching pancreatic cancer test:

This article was originally published in Clinica

Executive Summary

Response Genetics has initiated a two-year research study geared towards the development of a diagnostic test kit for pancreatic cancer. Los Angeles, California-based Response Genetics' technologies enable the extraction and analysis of genetic information from genes derived from formalin-fixed and paraffin embedded tumour samples. This information can be combined with patient outcomes data to aid in the development of assays and diagnostic tests for pancreatic cancer. The study will be conducted in collaboration with the University of California at San Francisco (UCSF), which will provide the tissue samples. According to the American Cancer Society, 33,370 US citizens will die from pancreatic cancer this year, with around 37,170 new cases being diagnosed in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel